Since then, the field of genomics has opened the door to understanding the genetic disposition to many neurologic diseases, including studying IDH mutations in gliomas and IDH1 mutations in glioblastomas, as well as understanding SCN1A mutations associated with epilepsy [74]. Here, IDH1 is linked to central nervous system cancer.